Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Galena Biopharma, Inc. (GALE) To Deliver Presentation At The 2014 Leerink Global Healthcare Conference

|Includes: SELLAS Life Sciences Group, Inc. (SLS)

Today before the opening bell, Galena Biopharma announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will be presenting a corporate update at the 2014 Leerink Global Healthcare Conference. The presentation will take place on Wednesday, February 12, 2014 at 3:55 p.m. ET at the Waldorf Astoria Hotel in New York, New York.

The presentation will be webcast and available on the investors section of the company's website at

Galena Biopharma is focused on developing and commercializing targeted oncology treatments to address major unmet medical needs and advance cancer care. The company's peptide vaccine immunotherapies harness the patient's own immune system to identify and destroy cancer cells. Utilizing peptide immunogens has many clinical advantages, including an excellent safety profile and long-lasting protection through immune system activation and convenient delivery.

MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit